Effect of Sucralfate on Helicobacter pylori and Severity of Gastritis in Patients with Duodenal Ulcer

References

• Porro Bianchi G, Parente F. Long-term management of duodenal ulcer. A review of management options. Drugs 1991; 41: 38–51
   PubMed Web of Science ®Google Scholar
• Lam S K. Implications of sucralfate induced ulcer hearing and relapse. Am J Med 1989; 86(Suppl 6A)122–6
   PubMed Web of Science ®Google Scholar
• Marks I N, Wright J P, Lucke W, Girdwood A H. Relapse rates after initial ulcer healing with sucralfate and cimetidine. Scand J Gastroenterol 1982; 17: 429–32
   PubMed Web of Science ®Google Scholar
• Moshal M G, Gregory M A, Pillay C, Spitaels J M. Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and De-Nol. Scand J Gastroenterol 1979; 14(Suppl 54)48–51
   Google Scholar
• Gregory M A, Moshal M G, Spitaels J M. Sucralfate versus cimetidine. A comparative study of mucosal morphology in duodenal ulcer healing (Abstract). Scand J Gastroenterol 1982; 17(Suppl 78)101
   Google Scholar
• Marks I N, Young G O. Changes in acid secretory response and parietal cell sensitivity on healing predict early relapse in patients with duodenal ulcer (Abstract). Am J Gastroenterol 1988; 3: 1075
   Google Scholar
• Marks I N, Young G O, Tigler-Wybrandi N A, Bridger S, Newton K A. Acid secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine. Am J Med 1989; 86(Suppl 6A)145–7
   PubMed Web of Science ®Google Scholar
• Coghlan J G, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, et al. Campylobacter pylori and recurrence of duodenal ulcers—a 12-month follow-up study. Lancet 1987; 2: 1109–11
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R, Murray R, Blincow E D, Blackbourn S J, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
   PubMed Web of Science ®Google Scholar
• Marshall B J, Armstrong J A, Francis G J, Nokes N T, Wee S H. Antibacterial effect of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 1987; 37(Suppl 2)16–30
   PubMed Web of Science ®Google Scholar
• Coghlan G, Gilligan D, Humphries H, McKenna D, Sweeney E. Efficacy of different dosage regimes in duodenal ulcer healing and Campylobacter pylori eradication. Abstract presented at the Irish Society of Gastroenterology, Londonderry, June, 5–61987
   Google Scholar
• Slomiany B L, Piotrowsky J, Samantha A, Van Horn K, Murty V LN, Slomiany A. Campylobacter pylori colonization factor shows specificity for lactosylceramide sulfate and GM3 gang-lioside. Biochem Int 1989; 19: 929–36
   PubMedGoogle Scholar
• Berstad A, Alexander B, Weberg R, Serck-Hanssen A, Holland S, Hirschowitz B. Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes. Gastroenterology 1988; 95: 619–24
   PubMed Web of Science ®Google Scholar
• Berstad K, Weberg R, Berstad A. Suppression of gastric urease activity by antacids. Scand J Gastroenterol 1990; 25: 496–500
   PubMed Web of Science ®Google Scholar
• Hui W M, Lam S K, Ho J, Ng I, Lau W, Branicki F, et al. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori. Am J Med 1989; 86(Suppl 6A)60–5
   PubMed Web of Science ®Google Scholar
• De Korwin J D, Vicari F, Chambre V, Foliquet B, Wahl D, Laurent J, . Follow up of Campylobacter pylori gastric infection after treatment of gastroduodenal ulcers with sucralfate or H2-blockers. Gastroduodenal pathology and Campylobacter pylori, F Megraud, H Lamouliatte, et al. Elsevier, Amsterdam 1989; 619–23
   Google Scholar
• Louw J A, Zak J, Lucke W, Le Roux E, Jaskiewicz K, Winter T A, et al. Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing relapse rates. Scand J Gastroenterol 1992; 27(Suppl 191)28–31
   Google Scholar
• Marshall B J, Warren J R, Francis G J, Langton S R. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol 1987; 82: 200–10
   PubMed Web of Science ®Google Scholar
• Jaskiewicz K, Lourens H D, Woodroof C W, Van Wyk M J, Price S K. The association of Campylobacter pylori with mucosal pathological changes in a population at risk for gastric cancer. S Afr Med J 1989; 75: 417–9
   PubMed Web of Science ®Google Scholar
• Debongnie J C, Pauwels S, Raat A, de Meeus Y, Haot J, Mainguet P. Quantification of Helicobacter pylori infection in gastritis and ulcer disease using a simple and rapid carbon-14-urea breath test. J Nucl Med 1991; 32: 1192–8
   PubMed Web of Science ®Google Scholar
• Tovey F I, Husband E M, Yiu Y C, Baker L, McPhail G, Lewin M R, et al. Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study. Gut 1989; 30: 586–93
   PubMed Web of Science ®Google Scholar
• Banerjee S, El Omar E, Mowat A, Ardill J ES, Park R HR, Watson W, et al. Sucralfate suppresses H. pylori infection and reduces gastric acid secretion by 50% in DU patients. Gut 1994; 35(Suppl 2)S35
   Google Scholar
• Vigneri S, Termini R, Scialabba A, Pisciotta G. Omeprazole therapy modifies the gastric localization of Helicobacter pylori. Am J Gastroenterol 1991; 86: 1276
   PubMed Web of Science ®Google Scholar
• Louw J A, Lucke W, Jaskiewicz K, van Rensburg C, Winter T A, Marks I N. Helicobacter pylori suppression by proton pump inhibitors (PPI's): A class effect? (Abstract). SAMJ 1993; 83: 784
   Google Scholar
• Louw J A, Zak J, Jaskiewicz K, Lastovica A J, Kotze T J, Lucke W, et al. Omeprazole may clear but does not eradicate H. pylori. Eur J Gastroenterol Hepatol 1992; 4: 481–5
   Web of Science ®Google Scholar